Skip to main content
Premium Trial:

Request an Annual Quote

Know How It's Used

Patients who agree to take part in genetic research might not be aware of how their data is being used, the Wall Street Journal reports. It adds that a number of hospital systems have entered into exclusive agreements to provide drugmakers access to patient data that patients might not know about.

For instance, the Journal writes that while the Geisinger health system tells patients that their studies might be funded by companies and that companies might take part in the work, it doesn't say that it has an exclusive arrangement with Regeneron Pharmaceuticals. Geisinger's David Ledbetter tells the Journal that focus groups they conducted found patients weren't concerned.

Some hospital researchers tell it that without the corporate investment, they wouldn't be able to conduct research or would have to rely on public funding. "We would have no data," Keith Stewart, director of Mayo Clinic's Center for Individualized Medicine, tells the Journal. "We don't have that kind of money sitting around." 

Arizona State University's Robert Cook-Deegan argues that patients should be made aware of the arrangements. "Donating to a nonprofit hospital that you trust and is in your community and that you think is a good thing is not the same thing as donating to a for-profit company," he tells the Journal.

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.